JAMES DAILEY: Open Payments
NPI 1730120759 · JOPLIN, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,625 in 131 payments from 24 companies in 2025. Trend: 2023 $1,756 · 2024 $1,986 · 2025 $2,625
Food & beverage: $2,625
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 36 | $447 |
| AstraZeneca Pharmaceuticals LP | 12 | $294 |
| PFIZER INC. | 17 | $276 |
| Amgen Inc. | 13 | $257 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $203 |
| Axsome Therapeutics, Inc. | 4 | $172 |
| Novo Nordisk Inc | 4 | $163 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $151 |
| Lilly USA, LLC | 7 | $125 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $71 |
Products named: VRAYLAR, CAPLYTA, NURTEC ODT, OTEZLA, JARDIANCE, Auvelity, FARXIGA, Ozempic.
Industry payments across MO — which companies pay providers there.
